According to reports, CFHR3 may be a potential biomarker for the disease hepatocellular carcinoma (HCC) [6]; however, as the second highest type of cancer in the liver, the correlation between CFHR3 expression and its clinical significance of CCA remains unclear. The gene discussed is CFHR3; the disease is hepatocellular carcinoma.